Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetylsalicylic acid + sodium chloride is a combination of two well-known compounds. Acetylsalicylic acid, commonly known as aspirin, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, anti-inflammatory, and antithrombotic properties. It works primarily by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins and thromboxanes, which mediate pain, inflammation, fever, and platelet aggregation[1][6]. Sodium chloride is an ionic compound used as an electrolyte replenisher in various medical formulations; it helps maintain osmotic balance and fluid distribution in the body[4]. While both agents are widely used individually for their respective indications—acetylsalicylic acid for pain relief and cardiovascular protection; sodium chloride for electrolyte balance—there is no evidence that this specific combination has unique pharmacological effects or clinical uses beyond those of its individual components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetylsalicylic acid + sodium chloride.